Data compiled by Redley Lamar · ChainSifter Intelligence
3Suppliers
3Customers
3Debt Items
0Related Chains
Source-Backed Evidence Depth
Ocugen, Inc. (OCGN) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
10Total relationships
3Distinct source URLs
8High confidence
0.850Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Ocugen, Inc. Suppliers
Ticker
Name
Confidence
Evidence
OPPENHEIMER-CO-INC
OPPENHEIMER-CO-INC
92%
the Company agreed to issue and sell to the Underwriter, in an offering
U-S-BANK-TRUST-COMPANY-NATIONAL-ASSOCIATION
U-S-BANK-TRUST-COMPANY-NATIONAL-ASSOCIATION
92%
The notes were issued pursuant to an indenture, dated May 7, 2026 (the “Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee.
CANSINO-BIOLOGICS-INC
CANSINO-BIOLOGICS-INC
90%
CanSinoBIO is responsible for the chemistry, manufacturing, and controls development and manufacture of clinical supplies of such products and is responsible for the costs associated with such activities.
Ocugen, Inc. Customers
Ticker
Name
Confidence
Evidence
KWANGDONG-PHARMACEUTICAL-LTD
KWANGDONG-PHARMACEUTICAL-LTD
92%
In accordance with the Kwangdong License, the Company received an initial $ 0.8 million (net of tax) non-refundable fee and is entitled to additional milestone-based fees upon FDA and regulatory appr…
CANSINO-BIOLOGICS-INC
CANSINO-BIOLOGICS-INC
62%
asure of performance and related revenue recognition. Adjustments to original estimates will be required as work progresses and additional information becomes known, even though the scope of the work…
DEVELOPMENT-AGREEMENTS-CO
DEVELOPMENT-AGREEMENTS-CO
62%
asure of performance and related revenue recognition. Adjustments to original estimates will be required as work progresses and additional information becomes known, even though the scope of the work…
Ocugen, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
OCGN-DEBT
Debt stack $1.7M
90%
Market cache reports total debt of $1.7M.
OCGN-DEBT-11484
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2022-12-31.
OCGN-DEBT-11483
Warrants outstanding: 156138
90%
xbrl warrant detail from xbrl 2026-03-31.
Ocugen, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Ocugen, Inc..
Ocugen, Inc. Ownership
Holder
Name
Confidence
Evidence
OCGN-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC
VANGUARD CAPITAL MANAGEMENT LLC
90%
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 140 tracked holders.
Ocugen, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
